HL

Hans Lennernäs

LA Lidds Ab: 6 patents #2 of 10Top 20%
SV Shire Viropharma: 1 patents #7 of 12Top 60%
Overall (All Time): #402,910 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11975105 Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders Göran Alderborn, Anders Forslund, Ulf Holmbäck, Jan Stefan Persson Grudén 2024-05-07
10583146 Pharmaceutical compositions for glucocorticoid replacement therapy Stanko Skrtic, Jörgen Johnsson, Thomas Hedner, Gudmundur Johannsson 2020-03-10
10561617 Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders Göran Alderborn, Anders Forslund, Ulf Holmbäck, Jan Stefan Persson Grudén 2020-02-18
9925139 Pharmaceutical compositions for acute glucocorticoid therapy Stanko Skrtic, Jörgen Johnsson, Thomas Hedner, Gudmundur Johannsson 2018-03-27
9198884 Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics Lars Åke Malmsten, Niklas Axén, Anders Carlsson 2015-12-01
9034359 Composition comprising biodegradable hydrating ceramics for controlled drug delivery Bo Lennernas, Jonas Hugosson, Niklas Axén 2015-05-19
8999389 Bioresorbable controlled-release composition Niklas Axén 2015-04-07
8936809 Method for treating prostate diseases based on local delivery of active substances Bo Lennernas, Jonas Hugosson, Niklas Axén 2015-01-20
8556495 Injector device Niklas Axén, Johan Yngve, Lars Åke Malmsten, Gunilla Eketorp, Åke G. Pilbrant 2013-10-15
8425937 Pharmaceutical compositions for glucocorticoid replacement therapy Stanko Skrtic, Jörgen Johnsson, Thomas Hedner, Gudmundur Johannsson 2013-04-23
8124118 Composition comprising biodegradable hydrating ceramics for controlled drug delivery Bo Lennernas, Jonas Hugosson, Niklas Axén 2012-02-28
6759059 Fentanyl composition for the treatment of acute pain Anders Pettersson, Christer Nystrom, Bo Lennernas, Thomas Hedner 2004-07-06